{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:35:09Z","timestamp":1777556109499,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Cilag GmbH Int."}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Various health technology assessment (HTA) agencies review new medical devices worldwide, and their recommendations can be useful in guiding clinical decision making. However, different agencies use different processes and methodologies, resulting in variation in recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The objectives were to review full HTAs for a new technology for diabetes management, flash glucose monitoring (FGM), with the aim of summarizing similarities\/differences in processes, methodologies, and recommendations from the perspective of everyday clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A literature review was conducted using online HTA resources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Four full HTAs were identified (Canary Islands, France, Catalunya, and Norway); one issued a conditional recommendation for patients with type 1 diabetes mellitus (T1DM) with controlled glycated hemoglobin (HbA1c) (Spain; Canary Islands), one issued a broader recommendation for patients with T1DM and T2DM (France), and two reported that there was insufficient evidence to support a recommendation (Spain [Catalunya] and Norway). The most comprehensive and stringent of the available HTAs were those in the Canary Islands and Norway, which included systematic literature reviews (SLRs), consultation with patient groups and clinicians, GRADE evidence quality assessments, and full economic models. Comprehensive HTAs either did not recommend FGM (Norway) or restricted the recommendation to a small subpopulation of the overall diabetes population (Canary Islands).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>HTAs represent a valuable additional resource for clinicians to consider alongside clinical evidence, guidelines, and consensus papers; however, interpreting recommendations requires an understanding of the processes behind these recommendations. In this review, comprehensive HTAs either recommended for a selected subpopulation based on RCT evidence or found insufficient evidence for a recommendation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1932296818794668","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T08:51:56Z","timestamp":1534927916000},"page":"584-591","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Health Technology Assessments for Flash Glucose Monitoring and How to Use Them in Everyday Clinical Practice"],"prefix":"10.1177","volume":"13","author":[{"given":"Magnus","family":"Stueve","sequence":"first","affiliation":[{"name":"Johnson & Johnson Medical GmbH, Norderstedt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[{"name":"Forschergruppe Diabetes e.V., Munich-Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"bibr1-1932296818794668","unstructured":"US Food and Drug Administration. Overview of device regulation. US Food and Drug Administration; 2018. https:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/Overview\/default.htm. Accessed February 2018."},{"key":"bibr2-1932296818794668","unstructured":"Medicines and Healthcare Products Regulatory Agency. Medical devices: conformity assessment and the CE mark. Medicines and Healthcare Products Regulatory Agency; 2018. https:\/\/www.gov.uk\/guidance\/medical-devices-conformity-assessment-and-the-ce-mark. Accessed February 2018."},{"key":"bibr3-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1512592"},{"key":"bibr4-1932296818794668","volume-title":"HTA 101: Introduction to Health Technology Assessment","author":"Goodman C.","year":"2014"},{"key":"bibr5-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.08.725"},{"key":"bibr6-1932296818794668","volume-title":"Medical Device Assessment in France: Guidebook","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2009"},{"key":"bibr7-1932296818794668","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health Care Excellence","year":"2013"},{"key":"bibr8-1932296818794668","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen. General Methods v5.0. 2017. https:\/\/www.iqwig.de\/download\/A05-08_Abschlussbericht_Zuckerselbstmessung_bei_Diabetes_mellitus_Typ_2.pdf. Accessed August 2018."},{"key":"bibr9-1932296818794668","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen. Urin- und Blutzuckerselbstmessung bei Diabetes mellitus Typ 2. 2009. https:\/\/www.has-sante.fr\/portail\/upload\/docs\/evamed\/CT-16059_FIASP_PIS_INS_Avis2_CT16059.pdf. Accessed August 2018."},{"key":"bibr10-1932296818794668","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Transparency Committee Opinion: insulin aspart. Paris, France: Haute Autorit\u00e9 de Sant\u00e9; 2017."},{"key":"bibr11-1932296818794668","unstructured":"Scottish Medicines Consortium. Insulin aspart (Fiasp\u00ae) 100 units\/mL solution for injection in vial; solution for injection in cartridge (Penfill\u00ae); solution for injection in pre-filled pen (FlexTouch\u00ae) SMC No. (1227\/17). 2017."},{"key":"bibr12-1932296818794668","unstructured":"TLV. Ans\u00f6kan inom l\u00e4kemedelsf\u00f6rm\u00e5nerna: Fiasp FlexTouch. 2017."},{"key":"bibr13-1932296818794668","author":"Pharmaceutical Benefits Advisory Committee","year":"2017","journal-title":"AstraZeneca;"},{"key":"bibr14-1932296818794668","unstructured":"Scottish Medicines Consortium. Saxagliptin 5mg\/dapagliflozin 10mg film-coated tablets (Qtern\u00ae) SMC No (1255\/17). 2017."},{"key":"bibr15-1932296818794668","unstructured":"TLV. Ans\u00f6kan inom l\u00e4kemedelsf\u00f6rm\u00e5nerna: Qtern. 2017."},{"key":"bibr16-1932296818794668","unstructured":"Context Matters. Diabetes\u2014adult type 2\u2014injectable\u20142016-2018. 2018."},{"key":"bibr17-1932296818794668","volume-title":"FreeStyle Libre for Glucose Monitoring","author":"National Institute for Health Care Excellence","year":"2017"},{"key":"bibr18-1932296818794668","volume-title":"Norwegian Institute of Public Health (Folkehelseinstitutttet)","author":"Bidonde J","year":"2017"},{"key":"bibr19-1932296818794668","volume-title":"CADTH Issues in Emerging Health Technologies","author":"Palylyk-Colwell E","year":"2017"},{"key":"bibr20-1932296818794668","unstructured":"Zorginstituut Nederland. Flash glucosemonitoringsysteem (FreeStyle Libre\u00ae). 2016."},{"key":"bibr21-1932296818794668","unstructured":"Programma regionale di valutazione delle Tecnologie sanitario, Giudizio di Priorita. FreeStyle Libre\u00ae - Sistema di monitoraggio continuo e non invasivo del glucosio nei fluidi interstiziali di pazienti con diabete mellito in trattamento insulinico intnsivo. 2016."},{"key":"bibr22-1932296818794668","unstructured":"Ag\u00e9ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e1ries de Catalunya, Generalitat de Catalunya, Departament de Salut. Informe aquas: Dispositiu Flash FreeStyle Libre\u00ae per al monitorage de la gluc\u00e9mia. 2016."},{"key":"bibr23-1932296818794668","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Commission Nationale d\u2019Evaluation des Dispositifs Medicaux et des Technologies de Sante: syst\u00e8me Freestyle Libre\u00ae d\u2019autosurvellance du glucose. 2016."},{"key":"bibr24-1932296818794668","unstructured":"Informes de Evaluaci\u00f3n Tecnolog\u00edas Sanitarias, Gobierno de Canarias. Efectividad, seguridad y coste-efectividad del sistema flash de monitorizacion de glucose en liquido interstiticial (Freestyle Libre\u00ae) para la Diabetes Mellitus tipo 1 y 2 2016."},{"key":"bibr25-1932296818794668","unstructured":"Abbott Diabetes Care. FreeStyle Libre in Pregnancy Study. NCT02665455. 2016."},{"key":"bibr26-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12907"},{"key":"bibr27-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0378"},{"key":"bibr28-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0495-8"},{"key":"bibr29-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-311530"},{"key":"bibr30-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000320"},{"key":"bibr31-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816662884"},{"key":"bibr32-1932296818794668","unstructured":"JPRN-UMIN000018692. Evaluation of validity of the advanced glucose monitoring (flash glucose monitoring). 2015."},{"key":"bibr33-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0392"},{"key":"bibr34-1932296818794668","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.192894"},{"key":"bibr35-1932296818794668","unstructured":"Abbott Diabetes Care. FreeStyle Libre Glucose Monitoring System Paediatric Study. NCT02821117. 2016."},{"key":"bibr36-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816661560"},{"key":"bibr37-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816653412"},{"key":"bibr38-1932296818794668","unstructured":"Cochrane Consumer Network. Levels of evidence. 2018. http:\/\/consumers.cochrane.org\/levels-evidence. Accessed February 2018."},{"key":"bibr39-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31535-5"},{"key":"bibr40-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-016-0223-6"},{"key":"bibr41-1932296818794668","unstructured":"BMJ Clinical Evidence. What is GRADE? 2012. http:\/\/clinicalevidence.bmj.com\/x\/set\/static\/ebm\/learn\/665072.html. Accessed December 2017."},{"key":"bibr42-1932296818794668","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.12.015"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1932296818794668","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1932296818794668","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1932296818794668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:13:26Z","timestamp":1777400006000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1932296818794668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1177\/1932296818794668"],"URL":"https:\/\/doi.org\/10.1177\/1932296818794668","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]}}}